Applied DNA Sciences Files 8-K on Shareholder Votes

Ticker: BNBX · Form: 8-K · Filed: Apr 16, 2024 · CIK: 744452

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, 8-k

Related Tickers: APDN

TL;DR

APDN filed an 8-K on shareholder votes, check for corporate governance updates.

AI Summary

Applied DNA Sciences, Inc. filed an 8-K on April 16, 2024, reporting on matters submitted to a vote of security holders as of April 15, 2024. The filing details the company's corporate structure, including its state of incorporation (Delaware) and principal executive office location in Stony Brook, New York.

Why It Matters

This filing indicates that Applied DNA Sciences is engaging in corporate governance processes, specifically related to shareholder voting, which can impact company direction and investor relations.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not appear to contain significant new financial or operational risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing states that the 8-K is for 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals voted upon within this initial report.

When was the earliest event reported in this 8-K?

The earliest event reported in this 8-K was on April 15, 2024.

What is Applied DNA Sciences, Inc.'s Commission File Number?

Applied DNA Sciences, Inc.'s Commission File Number is 001-36745.

Where is Applied DNA Sciences, Inc. headquartered?

Applied DNA Sciences, Inc.'s principal executive office is located at 50 Health Sciences Drive, Stony Brook, New York 11790.

What is the IRS Employer Identification Number for Applied DNA Sciences, Inc.?

The IRS Employer Identification Number for Applied DNA Sciences, Inc. is 59-2262718.

Filing Stats: 593 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-04-16 16:15:20

Key Financial Figures

Filing Documents

07

Item 5.07 Submission of Matters to a Vote of Security Holders. On April 15, 2024, Applied DNA Sciences, Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting"). The following proposals were voted on and were approved by the Company's stockholders at the Special Meeting with the stockholders having voted as set forth below: I. To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance to certain holders of common stock purchase warrants in connection with a private placement. FOR AGAINST ABSTAIN BROKER NON-VOTES 4,855,864 516,472 35,226 3,850,003 II. To approve, in accordance with Nasdaq Listing Rule 5635(d), the repricing of certain of our common stock purchase warrants. FOR AGAINST ABSTAIN BROKER NON-VOTES 4,826,983 541,578 39,001 3,850,003 III. To grant the Board of Directors discretionary authority to amend the Company's certificate of incorporation, as amended, to effect a reverse stock split of common stock, at a ratio in the range from one-for-five to one-for-fifty, with such specific ratio to be determined by the Company's Board of Directors following the Special Meeting. FOR AGAINST ABSTAIN BROKER NON-VOTES 8,360,021 824,051 73,493 0 IV. To approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of authorized shares of common stock reserved for issuance by 4,000,000 shares. FOR AGAINST ABSTAIN BROKER NON-VOTES 4,748,305 633,432 25,825 3,850,003 Each of the foregoing voting results from the Special Meeting is final. Based on the foregoing votes, each of the proposals was approved. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 16, 2024 APPLIED DNA SCIENCES, INC. By: /s/ James A. Hayward Name: James A. Hayward Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing